Hepatic IL-17 responses in human and murine primary biliary cirrhosis

Ruth Y Z Lan, Thucydides L. Salunga, Koichi Tsuneyama, Zhe Xiong Lian, Guo Xiang Yang, Willy Hsu, Yuki Moritoki, Aftab A. Ansari, Claudia Kemper, Jeff Price, John P. Atkinson, Ross L. Coppel, M. Eric Gershwin

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

The emergence of new regulatory and pro-inflammatory immune cell subsets and cytokines dictates the need to re-examine the role of these subsets in various diseases involving the immune system. IL-17 has been recently identified as a key cytokine involved in numerous autoimmune processes. However, its role in liver autoimmune diseases remains unclear. Primary biliary cirrhosis (PBC) is characterized histologically by autoreactive CD4 and CD8 T cells surrounding damaged bile ducts. CD4+ T cells are a major source of IL-17, which compose a distinct T helper subset (Th17). Thus we set out to determine the role of IL-17 in both human and a murine model of PBC in a liver-targeted manner. Our data demonstrate an increase in the frequency of IL-17+ lymphocytic infiltration in liver tissues from PBC patients and those with other liver dysfunctions as compared to healthy livers. IL-2 receptor α knockout mice, a recently identified murine model of human PBC, also demonstrate marked aggregations of IL-17-positive cells within portal tracts and increased frequencies of Th17 cells in the liver compared to the periphery. Interestingly, CD4+ T cells from livers of normal C57BL/6J mice also secreted higher levels of IL-17 relative to those from spleens, indicating a preferential induction of Th17 cells in liver tissues. Importantly, C57BL/6J cocultures of splenic CD4+ T cells and liver non-parenchymal cells increased IL-17 production approximately 10-fold compared to T cells alone, suggesting a role of the liver microenvironment in Th17 induction in cases of liver autoimmunity and other liver inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)43-51
Number of pages9
JournalJournal of Autoimmunity
Volume32
Issue number1
DOIs
StatePublished - Feb 2009

Fingerprint

Biliary Liver Cirrhosis
Interleukin-17
Liver
T-Lymphocytes
Th17 Cells
Liver Diseases
Cytokines
Interleukin-2 Receptors
Immune System Diseases
Coculture Techniques
Bile Ducts
Autoimmunity
Inbred C57BL Mouse
Knockout Mice
Autoimmune Diseases
Spleen

Keywords

  • CD46
  • CD T cells
  • IL-17
  • IL-2 receptor alpha
  • Liver
  • Microenvironment
  • Primary biliary cirrhosis
  • Tr1

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Lan, R. Y. Z., Salunga, T. L., Tsuneyama, K., Lian, Z. X., Yang, G. X., Hsu, W., ... Gershwin, M. E. (2009). Hepatic IL-17 responses in human and murine primary biliary cirrhosis. Journal of Autoimmunity, 32(1), 43-51. https://doi.org/10.1016/j.jaut.2008.11.001

Hepatic IL-17 responses in human and murine primary biliary cirrhosis. / Lan, Ruth Y Z; Salunga, Thucydides L.; Tsuneyama, Koichi; Lian, Zhe Xiong; Yang, Guo Xiang; Hsu, Willy; Moritoki, Yuki; Ansari, Aftab A.; Kemper, Claudia; Price, Jeff; Atkinson, John P.; Coppel, Ross L.; Gershwin, M. Eric.

In: Journal of Autoimmunity, Vol. 32, No. 1, 02.2009, p. 43-51.

Research output: Contribution to journalArticle

Lan, RYZ, Salunga, TL, Tsuneyama, K, Lian, ZX, Yang, GX, Hsu, W, Moritoki, Y, Ansari, AA, Kemper, C, Price, J, Atkinson, JP, Coppel, RL & Gershwin, ME 2009, 'Hepatic IL-17 responses in human and murine primary biliary cirrhosis', Journal of Autoimmunity, vol. 32, no. 1, pp. 43-51. https://doi.org/10.1016/j.jaut.2008.11.001
Lan RYZ, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. Journal of Autoimmunity. 2009 Feb;32(1):43-51. https://doi.org/10.1016/j.jaut.2008.11.001
Lan, Ruth Y Z ; Salunga, Thucydides L. ; Tsuneyama, Koichi ; Lian, Zhe Xiong ; Yang, Guo Xiang ; Hsu, Willy ; Moritoki, Yuki ; Ansari, Aftab A. ; Kemper, Claudia ; Price, Jeff ; Atkinson, John P. ; Coppel, Ross L. ; Gershwin, M. Eric. / Hepatic IL-17 responses in human and murine primary biliary cirrhosis. In: Journal of Autoimmunity. 2009 ; Vol. 32, No. 1. pp. 43-51.
@article{915cad82d506424ba80b0245b521c7db,
title = "Hepatic IL-17 responses in human and murine primary biliary cirrhosis",
abstract = "The emergence of new regulatory and pro-inflammatory immune cell subsets and cytokines dictates the need to re-examine the role of these subsets in various diseases involving the immune system. IL-17 has been recently identified as a key cytokine involved in numerous autoimmune processes. However, its role in liver autoimmune diseases remains unclear. Primary biliary cirrhosis (PBC) is characterized histologically by autoreactive CD4 and CD8 T cells surrounding damaged bile ducts. CD4+ T cells are a major source of IL-17, which compose a distinct T helper subset (Th17). Thus we set out to determine the role of IL-17 in both human and a murine model of PBC in a liver-targeted manner. Our data demonstrate an increase in the frequency of IL-17+ lymphocytic infiltration in liver tissues from PBC patients and those with other liver dysfunctions as compared to healthy livers. IL-2 receptor α knockout mice, a recently identified murine model of human PBC, also demonstrate marked aggregations of IL-17-positive cells within portal tracts and increased frequencies of Th17 cells in the liver compared to the periphery. Interestingly, CD4+ T cells from livers of normal C57BL/6J mice also secreted higher levels of IL-17 relative to those from spleens, indicating a preferential induction of Th17 cells in liver tissues. Importantly, C57BL/6J cocultures of splenic CD4+ T cells and liver non-parenchymal cells increased IL-17 production approximately 10-fold compared to T cells alone, suggesting a role of the liver microenvironment in Th17 induction in cases of liver autoimmunity and other liver inflammatory diseases.",
keywords = "CD46, CD T cells, IL-17, IL-2 receptor alpha, Liver, Microenvironment, Primary biliary cirrhosis, Tr1",
author = "Lan, {Ruth Y Z} and Salunga, {Thucydides L.} and Koichi Tsuneyama and Lian, {Zhe Xiong} and Yang, {Guo Xiang} and Willy Hsu and Yuki Moritoki and Ansari, {Aftab A.} and Claudia Kemper and Jeff Price and Atkinson, {John P.} and Coppel, {Ross L.} and Gershwin, {M. Eric}",
year = "2009",
month = "2",
doi = "10.1016/j.jaut.2008.11.001",
language = "English (US)",
volume = "32",
pages = "43--51",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Hepatic IL-17 responses in human and murine primary biliary cirrhosis

AU - Lan, Ruth Y Z

AU - Salunga, Thucydides L.

AU - Tsuneyama, Koichi

AU - Lian, Zhe Xiong

AU - Yang, Guo Xiang

AU - Hsu, Willy

AU - Moritoki, Yuki

AU - Ansari, Aftab A.

AU - Kemper, Claudia

AU - Price, Jeff

AU - Atkinson, John P.

AU - Coppel, Ross L.

AU - Gershwin, M. Eric

PY - 2009/2

Y1 - 2009/2

N2 - The emergence of new regulatory and pro-inflammatory immune cell subsets and cytokines dictates the need to re-examine the role of these subsets in various diseases involving the immune system. IL-17 has been recently identified as a key cytokine involved in numerous autoimmune processes. However, its role in liver autoimmune diseases remains unclear. Primary biliary cirrhosis (PBC) is characterized histologically by autoreactive CD4 and CD8 T cells surrounding damaged bile ducts. CD4+ T cells are a major source of IL-17, which compose a distinct T helper subset (Th17). Thus we set out to determine the role of IL-17 in both human and a murine model of PBC in a liver-targeted manner. Our data demonstrate an increase in the frequency of IL-17+ lymphocytic infiltration in liver tissues from PBC patients and those with other liver dysfunctions as compared to healthy livers. IL-2 receptor α knockout mice, a recently identified murine model of human PBC, also demonstrate marked aggregations of IL-17-positive cells within portal tracts and increased frequencies of Th17 cells in the liver compared to the periphery. Interestingly, CD4+ T cells from livers of normal C57BL/6J mice also secreted higher levels of IL-17 relative to those from spleens, indicating a preferential induction of Th17 cells in liver tissues. Importantly, C57BL/6J cocultures of splenic CD4+ T cells and liver non-parenchymal cells increased IL-17 production approximately 10-fold compared to T cells alone, suggesting a role of the liver microenvironment in Th17 induction in cases of liver autoimmunity and other liver inflammatory diseases.

AB - The emergence of new regulatory and pro-inflammatory immune cell subsets and cytokines dictates the need to re-examine the role of these subsets in various diseases involving the immune system. IL-17 has been recently identified as a key cytokine involved in numerous autoimmune processes. However, its role in liver autoimmune diseases remains unclear. Primary biliary cirrhosis (PBC) is characterized histologically by autoreactive CD4 and CD8 T cells surrounding damaged bile ducts. CD4+ T cells are a major source of IL-17, which compose a distinct T helper subset (Th17). Thus we set out to determine the role of IL-17 in both human and a murine model of PBC in a liver-targeted manner. Our data demonstrate an increase in the frequency of IL-17+ lymphocytic infiltration in liver tissues from PBC patients and those with other liver dysfunctions as compared to healthy livers. IL-2 receptor α knockout mice, a recently identified murine model of human PBC, also demonstrate marked aggregations of IL-17-positive cells within portal tracts and increased frequencies of Th17 cells in the liver compared to the periphery. Interestingly, CD4+ T cells from livers of normal C57BL/6J mice also secreted higher levels of IL-17 relative to those from spleens, indicating a preferential induction of Th17 cells in liver tissues. Importantly, C57BL/6J cocultures of splenic CD4+ T cells and liver non-parenchymal cells increased IL-17 production approximately 10-fold compared to T cells alone, suggesting a role of the liver microenvironment in Th17 induction in cases of liver autoimmunity and other liver inflammatory diseases.

KW - CD46

KW - CD T cells

KW - IL-17

KW - IL-2 receptor alpha

KW - Liver

KW - Microenvironment

KW - Primary biliary cirrhosis

KW - Tr1

UR - http://www.scopus.com/inward/record.url?scp=58849115337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849115337&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2008.11.001

DO - 10.1016/j.jaut.2008.11.001

M3 - Article

C2 - 19101114

AN - SCOPUS:58849115337

VL - 32

SP - 43

EP - 51

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 1

ER -